High confidence in Aurinia Pharmaceuticals with anticipated ...
High confidence in Aurinia Pharmaceuticals with anticipated average yearly growth rate of 71%. A slower rate will delay profitability. Company's debt-free status lowers investment risk.
When Can We Expect A Profit From Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)?
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment